Literature DB >> 32560616

Anticancer Perspectives on the Fungal-Derived Polyphenolic Hispolon.

Muhammad T Islam1,2, Eunus S Ali3,4, Ishaq N Khan5, Subrata Shaw6, Shaikh Jamal Uddin7, Razina Rouf8, Shrabanti Dev7, Seyed S S Saravi9,10, Niranjan Das11, Swati Tripathi12, Santosh U Yele13, Asish K Das7, Jamil A Shilpi7, Siddhartha K Mishra14, Mohammad S Mubarak15.   

Abstract

BACKGROUND: Cancer is a dreadful disease causing thousands of deaths per year worldwide, which requires precision diagnostics and therapy. Although the selection of therapeutic regimens depends on the cancer type, chemotherapy remains a sustainable treatment strategy despite some of its known side-effects. To date, a number of natural products and their derivatives or analogues have been investigated as potent anticancer drugs. These drug discoveries have aimed for targeted therapy and reduced side-effects, including natural therapeutic regimens.
OBJECTIVE: This review introduces a prospective fungal-derived polyphenol, Hispolon (HIS), as an anticancer agent. Accordingly, this review focuses on exploring the anticancer effect of hispolon based on information extracted from databases such as PubMed, ScienceDirect, MedLine, Web of Science, and Google Scholar.
METHODS: A literature search in PubMed, ScienceDirect, MedLine, Web of Science, and Google Scholar was accomplished, using the keyword 'Hispolon', pairing with 'cancer', 'cytotoxicity', 'cell cycle arrest', 'apoptosis', 'metastasis', 'migration', 'invasion', 'proliferation', 'genotoxicity', 'mutagenicity', 'drug-resistant cancer', 'autophagy', and 'estrogen receptor.
RESULTS: Database-dependent findings from reported research works suggest that HIS can exert anticancer effects by modulating multiple molecular and biochemical pathways, including cell cycle arrest, apoptosis, autophagy, inhibition of proliferation, metastasis, migration, and invasion. Moreover, HIS inhibits the estrogenic activity and exhibits chemoprevention prospects, possibly due to its protective effects such as anticancer and anti-inflammatory mechanisms. To date, a number of HIS derivatives and analogues have been introduced for their anticancer effects in numerous cancer cell lines.
CONCLUSION: Data obtained from this review suggest that hispolon and some of its derivatives can be promising anticancer agents, and may become plant-based cancer chemotherapeutic leads for the development of potent anticancer drugs, alone or in combination with other chemotherapeutic agents. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Polyphenol; cancer; chemotherapy; drug-resistant cells; hispolon; mechanism of action

Mesh:

Substances:

Year:  2020        PMID: 32560616     DOI: 10.2174/1871520620666200619164947

Source DB:  PubMed          Journal:  Anticancer Agents Med Chem        ISSN: 1871-5206            Impact factor:   2.505


  2 in total

1.  Dehydroxyhispolon Methyl Ether, A Hispolon Derivative, Inhibits WNT/β-Catenin Signaling to Elicit Human Colorectal Carcinoma Cell Apoptosis.

Authors:  Hueng-Chuen Fan; Ya-Chu Hsieh; Li-Hsuan Li; Ching-Chin Chang; Karolína Janoušková; Modukuri V Ramani; Gottumukkala V Subbaraju; Kur-Ta Cheng; Chia-Che Chang
Journal:  Int J Mol Sci       Date:  2020-11-22       Impact factor: 5.923

2.  Regular Intake of Green Tea Polyphenols Suppresses the Development of Nonmelanoma Skin Cancer through miR-29-Mediated Epigenetic Modifications.

Authors:  Vikash Kansal; Anshu Agarwal; Angela Harbour; Humaira Farooqi; Vijay Kumar Singh; Ram Prasad
Journal:  J Clin Med       Date:  2022-01-13       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.